Background: This study evaluated the accuracy, clinical concordance, and readability of the chatbot interface generative pretrained transformer (ChatGPT) 3.5 as a source of breast cancer information for patients.
Methods: Twenty questions that patients are likely to ask ChatGPT were identified by breast cancer advocates.